No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs542224089 |
chr9:97139130-97139131 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs386736420 |
chr9:97139161-97139162 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs576376111 |
chr9:97139162-97139163 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs543687056 |
chr9:97139227-97139228 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs565509091 |
chr9:97139228-97139229 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs532613289 |
chr9:97139372-97139373 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs541586942 |
chr9:97139398-97139399 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs559597060 |
chr9:97139468-97139469 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs552178670 |
chr9:97139504-97139505 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs142101771 |
chr9:97139549-97139550 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs530959760 |
chr9:97139667-97139668 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs112117727 |
chr9:97139724-97139725 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs531669146 |
chr9:97139812-97139813 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs373095439 |
chr9:97139835-97139836 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs72412731 |
chr9:97139836-97139837 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs150798745 |
chr9:97139838-97139839 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs140793638 |
chr9:97139841-97139842 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs549819767 |
chr9:97139856-97139857 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs183197256 |
chr9:97139891-97139892 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs2769720 |
chr9:97139928-97139929 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs397834963 |
chr9:97139929-97139930 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs538456590 |
chr9:97140005-97140006 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs553890206 |
chr9:97140006-97140007 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs565477658 |
chr9:97140090-97140091 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs186061407 |
chr9:97140118-97140119 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs554171766 |
chr9:97140150-97140151 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs191556527 |
chr9:97140154-97140155 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs556111479 |
chr9:97140194-97140195 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs575617332 |
chr9:97140230-97140231 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs148583286 |
chr9:97140231-97140232 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs536615467 |
chr9:97140258-97140259 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs559010003 |
chr9:97140259-97140260 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs182880468 |
chr9:97140300-97140301 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541276667 |
chr9:97140318-97140319 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs559890005 |
chr9:97140320-97140321 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs2479639 |
chr9:97140334-97140335 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs575036347 |
chr9:97140340-97140341 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs563674570 |
chr9:97140346-97140347 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs188150839 |
chr9:97140364-97140365 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs563735546 |
chr9:97140386-97140387 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs549809830 |
chr9:97140395-97140396 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs71366229 |
chr9:97140408-97140409 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs552495669 |
chr9:97140415-97140416 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs2479637 |
chr9:97140430-97140431 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs568166601 |
chr9:97140513-97140514 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs4398990 |
chr9:97140542-97140543 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
47 |
rs368297834 |
chr9:97140588-97140589 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs532425810 |
chr9:97140612-97140613 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs547320510 |
chr9:97140617-97140618 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs565516346 |
chr9:97140627-97140628 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|